Oliver Lagore Vanvalin Investment Group’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,180
Closed -$7.29K 693
2024
Q2
$7.29K Buy
+1,180
New +$7.29K ﹤0.01% 454